Pelthos Therapeutics Inc.
PTHS
$24.82
-$0.32-1.27%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.41M | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.41M | -- | -- | -- | -- |
| Cost of Revenue | 2.46M | 514.80K | 194.30K | -894.20K | 415.00K |
| Gross Profit | 4.95M | -514.80K | -194.30K | 894.20K | -415.00K |
| SG&A Expenses | 19.63M | 2.72M | 1.64M | 1.54M | 1.63M |
| Depreciation & Amortization | 679.00K | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.77M | 3.23M | 1.83M | 1.83M | 2.05M |
| Operating Income | -15.36M | -3.23M | -1.83M | -1.83M | -2.05M |
| Income Before Tax | -16.70M | -3.45M | -1.97M | -1.93M | -1.70M |
| Income Tax Expenses | -465.00K | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.24M | -3.45M | -1.97M | -1.93M | -1.70M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.24M | -3.45M | -1.97M | -1.93M | -1.70M |
| EBIT | -15.36M | -3.23M | -1.83M | -1.83M | -2.05M |
| EBITDA | -15.01M | -- | -- | -- | -- |
| EPS Basic | -5.30 | -5.38 | -3.21 | -3.19 | -2.93 |
| Normalized Basic EPS | -3.41 | -3.37 | -2.01 | -1.99 | -1.83 |
| EPS Diluted | -5.30 | -5.38 | -3.21 | -3.19 | -2.93 |
| Normalized Diluted EPS | -3.41 | -3.37 | -2.01 | -1.99 | -1.83 |
| Average Basic Shares Outstanding | 3.06M | 640.50K | 612.80K | 603.70K | 579.20K |
| Average Diluted Shares Outstanding | 3.06M | 640.50K | 612.80K | 603.70K | 579.20K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |